Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
79.5M
-
Shares change
-
-2.14M
-
Total reported value, excl. options
-
$554M
-
Value change
-
-$221M
-
Put/Call ratio
-
0.57
-
Number of buys
-
65
-
Number of sells
-
-72
-
Price
-
$6.96
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2021
188 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2021.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
of 170M outstanding shares and own 46.64% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (14.4M shares), FMR LLC (13.8M shares), STATE STREET CORP (10M shares), FEDERATED HERMES, INC. (7.18M shares), BlackRock Inc. (5.84M shares), JANUS HENDERSON GROUP PLC (4.34M shares), VANGUARD GROUP INC (3.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.36M shares), TWO SIGMA INVESTMENTS, LP (999K shares), and GEODE CAPITAL MANAGEMENT, LLC (955K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.